One of the key advantages of spectral flow cytometry is its ability to extract sample autofluorescence, making it much easier to resolve populations of interest.  Learn more about this powerful capability for the Cytek Aurora & Northern Lights.

Intravital microscopy can visualize various in vivo cellular-level dynamics such as cell trafficking, cell-to-cell or cell-to-microenvironment interactions in a living animal. Intravital imaging of pathophysiological cellular dynamics in natural in vivo microenvironment in various preclinical animal model can provide an unprecedented insight in the dynamic processes of human diseases beyond conventional histological observation of ex vivo sample or in vitro culture sample.

Bacteria and fungi organized into biofilms are highly refractory to known antibiotics and biocides. To develop new solutions to combat biofilms, screening technologies must be designed to grow biofilms under conditions that represent an in vivo or in situ community while maintaining the ability to add and observe the effects of compounds.

Understanding how cells organize the array of components within their membranous confines can not only provide insight into essential homeostatic functions it can also shed light on disorganized regions within the cell.

NanoView Biosciences has developed a unique technology for purification-free analysis of extracellular vesicles and viruses. Exosomes are affinity captured onto a protein microarray (ExoView chip) via common or custom exosomal markers.

Immuno-oncology (IO) has transformed cancer treatment. The number of treatments in the IO pipeline continues to increase.  If the treatment is CAR-T cells, adoptive T cell therapy or checkpoint inhibitors, the mechanism of action includes T cell lyse.

NanoView Biosciences has developed a unique technology for purification-free analysis of extracellular vesicles and viruses. Exosomes are affinity captured onto a protein microarray (ExoView chip) via common or custom exosomal markers.

Bacteria and fungi organized into biofilms are highly refractory to known antibiotics and biocides. To develop new solutions to combat biofilms, screening technologies must be designed to grow biofilms under conditions that represent an in vivo or in situ community while maintaining the ability to add and observe the effects of compounds.

In conventional fluorescence cytometry, each fluorophore in a panel is measured in a target detector, through the use of wide band-pass optical filters. In contrast, spectral cytometry uses a large number of detectors with narrow band-pass filters.